zilucoplan
zilucoplan is listed in the FDA National Drug Code directory with 3 NDC codes, marketed under brand name including ZILBRYSQ. Available dosage form: injection, solution.
Drug Details
- Generic Name
- zilucoplan
- Brand Names
- ZILBRYSQ
- Application Number
- NDA216834
- Sponsor
- UCB, Inc.
- NDC Codes
- 3
- Dosage Forms
- INJECTION, SOLUTION
- Routes
- SUBCUTANEOUS
- Active Ingredients
- ZILUCOPLAN
Indications and Usage
1 INDICATIONS AND USAGE ZILBRYSQ is indicated for the treatment of generalized myasthenia gravis (gMG) in adult patients who are anti-acetylcholine receptor (AChR) antibody positive. ZILBRYSQ is a complement inhibitor indicated for the treatment of generalized myasthenia gravis (gMG) in adult patients who are anti-acetylcholine receptor (AChR) antibody positive. ( 1 )